Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taikang Biopharmaceutical is a high-tech enterprise based in Taizhou, China, specializing in the research, development, and manufacturing of therapeutic biological drugs. The company focuses on large-molecule biologics, particularly monoclonal antibodies and recombinant proteins, targeting autoimmune diseases and oncology. Taikang Biopharmaceutical operates a large-scale production facility that meets international GMP standards, supporting both its internal pipeline and potential contract manufacturing services. Its portfolio includes biosimilars and innovative biologics aimed at providing affordable, high-quality treatments for chronic and life-threatening conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Taikang Biopharmaceutical.